Reaffirmed Full Year Revenue Guidance and Raised Full Year Guidance for Net Loss and Adjusted EBITDA Deficit Webcast at 4:30 pm ET, August 8, 2023 SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a …
Q2 total revenue of $39.6 million, up 39% year-over-year, at high end of guidance range Q2 subscription revenue reached record $20.9 million, at high end of guidance range Q2 GAAP loss per share of $0.19 and Non-GAAP loss per share of $0.07, at high end of …
Received FDA clearance of IND application for brain-penetrant MEK inhibitor, KIN-7136; expect to enter the clinic with Phase 1 trial in the second half of 2023 Cash, cash equivalents and investments of $204.3 million as of June 30, 2023 anticipated to fund …
SEATTLE, Aug. 08, 2023 (GLOBE NEWSWIRE) -- DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading developer and publisher of digital games on mobile and web-based platforms, today announced its unaudited financial results …
DEVON, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) (the “Company”), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced that …
BOSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel small molecule therapeutics to benefit patients with diseases of the immune system, today announced that Christophe Arbet- …
Quarterly revenue of $82.7 million, representing an increase of 8% year-over-year. Second quarter gross margin of 67.4% and an increase in gross profit of 6% year-over-year. Active Buyers of 1.7 million and Orders of 1.8 million in Q2 2023, representing a …
Cash, cash equivalents and marketable securities of $632.7 million as of June 30, 2023 support advancing multiple product candidates through key clinical milestones Remain on track for initial clinical data from two lead product candidates in 2024 Further …
AUBURN, Ala., Aug. 08, 2023 (GLOBE NEWSWIRE) -- On August 8, 2023, the Board of Directors of Auburn National Bancorporation, Inc. (the “Company”) (Nasdaq: AUBN) declared a third quarter $0.27 per share cash dividend, payable September 25, 2023 to …
Annualized recurring revenue (“ARR”) of $751 million, an increase of 14% year-over-year Total revenue of $190 million, up 14% year-over-year; Products revenue of $182 million, up 14% year-over-year GAAP operating loss of $52 million; Non-GAAP operating …
HOUSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) (“Skyward Specialty” or the “Company”) today reported second quarter 2023 net income of $19.5 million, or $0.51 per diluted share, compared to $5.1 million, …
- In new data from Icosavax’s IVX-121 Phase 1b extension trial in older adults, GMTs against RSV through day 365 persisted at ~45-70% of the GMTs at day 28 (for 75 and 250 µg unadjuvanted dosages) - - Data provide additional clinical evidence of potential …
Enrollment continues in global Phase 3 SUNRISE-3 trial evaluating bemnifosbuvir for treatment of COVID-19 Phase 3 SUNRISE-3 trial protocol amended to broaden eligibility criteria for high-risk patients and adapt to current COVID-19 environment Enrollment …
AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), an industry trailblazer in lending enablement and risk analytics solutions for financial institutions, today reported financial …
Second Quarter Revenue Increases 28% Over Prior Quarter Cable Revenue Improves by 79% From Prior Quarter Working Capital Position Substantially Improves Current Deferred Revenue Position Up $22 Million Since Year End Successfully Refinanced Term Loan B in …
Net Cash Provided by Operating Activities of $11.3 Million, a 19.5% Increase from $9.4 Million in Q2 2022 Invoiced Cloud Revenue Increased 24.0% to a Record $46.4 Million, Supported by Thirteenth Consecutive Quarter of Double-Digit Cloud Subscriber Growth …
2Q 2023 total tons sold of approximately 1.1 million 2Q 2023 revenue of $74.8 million 2Q 2023 net income of $6.3 million 2Q 2023 adjusted EBITDA of $11.4 million 2Q 2023 net cash provided by operating activities of $16.1 million 2Q 2023 free cash flow of $ …
Q2 total revenue year-over-year growth of 17% to $135.1 million ARR year-over-year growth of 18% to $547.8 million as of June 30, 2023 Cash flow provided by operations of $60.4 million for the TTM ended June 30, 2023, or 12% of TTM total revenue; unlevered …
ATHENS, Greece, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The Board of Directors of Capital Product Partners L.P. (NASDAQ: CPLP) (the “Partnership”) has called an annual meeting of the Limited Partners to be held at the Partnership’s headquarters in Greece on …
Data from the Phase 1 dose escalation portion of the Phase 1/2 KB-0742 study will be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in October 2023 The Company recently opened the third dosing cohort …
02 days 18:19:37
